Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression

Fig. 2

Kaplan-Meier survival analysis in patients with NSCLC. a and b Kaplan-Meier analysis of overall and recurrence-free survival according to FoxC2 expression level. c and d Subsets of patients with squamous cell carcinoma and adenocarcinoma. e and f Subsets of male and female patients. g and h Subsets of smokers and never smokers. i and j Subsets of pT status. k and l Subsets of pN status. High FoxC2 expression was associated with both shortened survival and increased recurrence in the entire cohort of patients. Subset analyses indicated that patients with high FoxC2 expression had a worse prognosis regardless of gender, smoking status and pT status. As for patients with squmous cell carcinoma and those without nodal involvement, FoxC2 was not found to be prognostic

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us